Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 9,001–9,020 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Lipo MIC-12 Compound Injectable a) NDC 69699-1603-10; b) 30 mL Stock Solution Compound Injectable NDC 69699-1603-30, Pharm D Solutions, Houston, Texas

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Levocarnitine 170 mg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1617-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG 6000 unit/0.3 gm Mannitol Lyopholized 6000 IU/vial injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1739-06

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG 50,000 unit/0.3 gm Mannitol Lyophilized Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1736-50

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG 4000 Unit Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1704-01

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG 3000 Unit Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1738-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG Lyopholized 1200 IU Injectable, Pharm D Solutions, Houston, Texas ---- NDC 69699-1743-12

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG 10,000 unit/0.3 gm Mannitol Lyopholized, Pharm D Solutions, Houston, Texas ---- NDC 69699-1711-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG Reconstitued 6000 IU Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1739-06

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG Reconstitued 50,000 IU Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1736-50

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

HCG Lyophilized 5000 IU Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-1707-10

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Glycerin 72% (Lidocaine/Epi 2:1) Injectable, Pharm D Solutions, Houston, Texas ---- NDC 69699-1401-30

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Glutathione 200 mg/mL Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1504-30

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Glutamine 10 mg/mL Solution, Pharm D Solutions, Houston, Texas ---- NDC 69699-1439-59

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Epinepherine 1 mg/1 mL 3 mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-0109-03

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Epi-Shugarcaine Kit Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1409-60

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Dexpanthenol Injection, 250 mg/mL Pharm D Solutions, Houston, Texas --- NDC 69699-1610-30

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Calcium Gluconate 2.5% a) 250 mL 25 mg/mL NDC 69699-0908-25; b) Nasal Spray 2.5 Inhal Soln. NDC 69699-0908-10; c) Nebulization Solution 2.5% Inhal. Soln NDC 69699-0908-10; d) Nebulization 250 mL 2.5% Inhal Soln NDC 69699-0908-25; e) Oral Spray 2.5% 2.5% Oral Soln NDC 69699-0917-60, Pharm D Solutions, Houston, Texas

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Calcium Gluconate 10%, 100 mg/mL Injectable, Pharm D Solutions, Houston, Texas ---- NDC 69699-0914-30

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Calcium Gluconate1% Eyewash 10 mg/mL, 125 mL bottles, Pharm D Solutions, Houston, Texas ---- NDC 69699-0906-12

by Pharm D Solutions, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 10, 2018
Reported by FDA
November 7, 2018
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.